Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan-based triple therapy vs omeprazole-based standard therapy for Helicobacter pylori eradication
TCTR20221226002Phase 3Unknown
- Sponsor
- Phramongkutklao Hospital
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vonoprazan, omeprazole, amoxicillin, levofloxacin in Helicobacter pylori infection, sponsored by Phramongkutklao Hospital. Status: unknown.
02
Drugs
vonoprazanomeprazoleamoxicillinlevofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on TCTR20221226002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221226002.